{
    "title": "GSK faces fury from investors over multibillion bid for expanding its consumer healthcare business",
    "url": "https://www.dailymail.co.uk/money/markets/article-4505344/GSK-faces-fury-investors-8-billion-deal.html",
    "date": "2017-05-14",
    "keywords": [
        "growth",
        "drug",
        "gsk",
        "threat",
        "woodford",
        "consumer",
        "share",
        "blockbuster",
        "glaxosmithkline",
        "bruising",
        "runin",
        "takeover",
        "plan",
        "star",
        "investor",
        "giant",
        "rival",
        "cent",
        "stake",
        "healthcare",
        "fury",
        "move",
        "firm",
        "control",
        "nicorette",
        "beechamsbut",
        "decision",
        "refusal",
        "breakup",
        "sustainability",
        "dividend",
        "bmi",
        "eu",
        "business",
        "use",
        "value",
        "article",
        "fund",
        "lack",
        "confidence",
        "shareholdershe",
        "glaxo",
        "patience",
        "split",
        "businessesthe",
        "sum",
        "whole",
        "viewpoint",
        "repeatedlyhe",
        "hiv",
        "treatment",
        "division",
        "half",
        "companys",
        "engine",
        "future",
        "revenue",
        "cash",
        "advairglaxo",
        "hikma",
        "cutprice",
        "equivalent",
        "advair",
        "shortterm",
        "boost",
        "week",
        "application",
        "executive",
        "emma",
        "walmsley",
        "structure",
        "vaccine",
        "weight",
        "pressure",
        "kind",
        "multibillionpound",
        "pharma",
        "rivalsthe",
        "company",
        "lookout",
        "stage"
    ],
    "category": [
        "money",
        "markets"
    ]
}